Neurobiology of attention deficit/hyperactivity disorder

Pediatric Research

Volumn 69, Issue 5 PART 2, 2011, Pages

  Purper Ouakil, Diane ^a,b   Ramoz, Nicolas ^a   Lepagnol Bestel, Aude Marie ^c   Gorwood, Philip ^a,d   Simonneau, Michel ^a  

^a INSERM   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^d CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; CATECHOLAMINERGIC SYSTEM; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CYTOARCHITECTURE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHENOTYPE;

EID: 79954622229     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318212b40f     Document Type: Article

References (79)

1. Biederman J 1998 Attention-deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry 59:4-16 (Pubitemid 28317217)
2. Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R, Stefansson H, Stefansson K, Magnusson P, Gudmundsson OO, Holmans P, Owen MO, O'Donovan M, Thapar A 2010 Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376:1401-1408
3. Burbach JP 2010 Neuropsychiatric connexions of ADHD genes. Lancet 376:1367-1368
4. Faraone SV, Biederman J 1994 Is attention deficit hyperactivity disorder familial? Harv Rev Psychiatry 1:271-287 (Pubitemid 24076396)
5. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P 2005 Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323 (Pubitemid 40798551)
6. Boomsma DI, Saviouk V, Hottenga JJ, Distel MA, de Moor MH, Vink JM, Geels LM, van Beek JH, Bartels M, de Geus EJ, Willemsen G 2010 Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults. PLoS One 5:e10621
7. Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV 2000 Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 39:1432-1437
8. Nikolas MA, Burt SA 2010 Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis. J Abnorm Psychol 119:1-17
9. Talge NM, Neal C, Glover V 2007 Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 48:245-261 (Pubitemid 46372120)
10. Ribas-Fitó N, Torrent M, Carrizo D, Júlvez J, Grimalt JO, Sunyer J 2007 Exposure to hexachlorobenzene during pregnancy and children's social behavior at 4 years of age. Environ Health Perspect 115:447-450 (Pubitemid 46554446)
11. Pineda DA, Palacio LG, Puerta IC, Merchan V, Arango CP, Galvis AY, Gomez M, Aguirre DC, Lopera F, Arcos-Burgos M 2007 Environmental influences that affect attention deficit/hyperactivity disorder: study of a genetic isolate. Eur Child Adolesc Psychiatry 16:337-346 (Pubitemid 47305459)
12. Strang-Karlsson S, Raikkonen K, Pesonen AK, Kajantie E, Paavonen EJ, Lahti J, Hovi P, Heinonen K, Jarvenpaa AL, Eriksson JG, Andersson S 2008 Very low birth weight and behavioral symptoms of attention deficit hyperactivity disorder in young adulthood: the Helsinki study of very-low-birth-weight adults. Am J Psychiatry 165:1345-1353
13. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ 2002 Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 288:728-737 (Pubitemid 34848226)
14. Nicolescu R, Petcu C, Cordeanu A, Fabritius K, Schlumpf M, Krebs R, Kramer U, Winneke G 2010 Environmental exposure to lead, but not other neurotoxic metals, relates to core elements of ADHD in Romanian children: performance and ques-tionnaire data. Environ Res 110:476-483
15. Jacobson JL, Jacobson SW 2003 Prenatal exposure to polychlorinated biphenyls and attention at school age. J Pediatr 143:780-788 (Pubitemid 37510650)
16. Biederman J, Milberger S, Faraone SV, Kiely K, Guite J, Mick E, Ablon S, Warburton R, Reed E 1995 Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatry 52:464-470
17. Ellis B, Nigg J 2009 Parenting practices and attention-deficit/ hyperactivity disorder: new findings suggest partial specificity of effects. J Am Acad Child Adolesc Psychiatry 48:146-154
18. Counts CA, Nigg JT, Stawicki JA, Rappley MD, von Eye A 2005 Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems. J Am Acad Child Adolesc Psychiatry 44:690-698 (Pubitemid 40875364)
19. Rutter M, Sonuga-Barke EJ 2010 X. Conclusions: overview of findings from the era study, inferences, and research implications. Monogr Soc Res Child Dev 75:212-229
20. D'Onofrio BM, Van Hulle CA, Waldman ID, Rodgers JL, Harden KP, Rathouz PJ, Lahey BB 2008 Smoking during pregnancy and offspring externalizing problems: an exploration of genetic and environmental confounds. Dev Psychopathol 20:139-164 (Pubitemid 351166710)
21. Rice F, Thapar A 2010 Estimating the relative contributions of maternal genetic, paternal genetic and intrauterine factors to offspring birth weight and head circum-ference. Early Hum Dev 86:425-432
22. Hicks BM, South SC, Dirago AC, Iacono WG, McGue M 2009 Environmental adversity and increasing genetic risk for externalizing disorders. Arch Gen Psychiatry 66:640-648
23. Barkley RA 1997 Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121:65-94 (Pubitemid 127705285)
24. Sergeant JA, Geurts H, Huijbregts S, Scheres A, Oosterlaan J 2003 The top and the bottom of ADHD: a neuropsychological perspective. Neurosci Biobehav Rev 27:583-592 (Pubitemid 37414907)
25. Sonuga-Barke EJ 2003 The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev 27:593-604 (Pubitemid 37414908)
26. Rommelse NN, Altink ME, Oosterlaan J, Beem L, Buschgens CJ, Buitelaar J, Sergeant JA 2008 Speed, variability, and timing of motor output in ADHD: which measures are useful for endophenotypic research? Behav Genet 38:121-132
27. Biederman J, Petty CR, Ball SW, Fried R, Doyle AE, Cohen D, Henderson C, Faraone SV 2009 Are cognitive deficits in attention deficit/hyperactivity disorder related to the course of the disorder? A prospective controlled follow-up study of grown up boys with persistent and remitting course. Psychiatry Res 170:177-182
28. Bidwell LC, Willcutt EG, Defries JC, Pennington BF 2007 Testing for neuropsy-chological endophenotypes in siblings discordant for attention-deficit/hyperactivity disorder. Biol Psychiatry 62:991-998 (Pubitemid 47562370)
29. Rommelse NN, Arias-Vasquez A, Altink ME, Buschgens CJ, Fliers E, Asherson P, Faraone SV, Buitelaar JK, Sergeant JA, Oosterlaan J, Franke B 2008 Neuropsycho-logical endophenotype approach to genome-wide linkage analysis identifies suscep-tibility loci for ADHD on 2q21.1 and 13q12.11. Am J Hum Genet 83:99-105
30. Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, Buitelaar J, Castellanos FX, Doyle A, Ebstein RP, Ekholm J, Forabosco P, Franke B, Freitag C, Friedel S, Gill M, Hebebrand J, Hinney A, Jacob C, Lesch KP, Loo SK, Lopera F, McCracken JT, McGough JJ, Meyer J, Mick E, Miranda A, Muenke M, Mulas F, Nelson SF, Nguyen TT, Oades RD, Ogdie MN, Palacio JD, Pineda D, Reif A, Renner TJ, Roeyers H, Romanos M, Rothenberger A, Schäfer H, Sergeant J, Sinke RJ, Smalley SL, Sonuga-Barke E, Steinhausen HC, van der Meulen E, Walitza S, Warnke A, Lewis CM, Faraone SV, Asherson P 2008 Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B:1392-1398
31. Li D, Sham PC, Owen MJ, He L 2006 Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). HumMol Genet 15:2276-2284 (Pubitemid 43994869)
32. Gizer IR, Ficks C, Waldman ID 2009 Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 126:51-90
33. Smoller JW, Biederman J, Arbeitman L, Doyle AE, Fagerness J, Perlis RH, Sklar P, Faraone SV 2006 Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry 59:460-467 (Pubitemid 43289227)
34. Mick E, Faraone SV 2008 Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17:261-284 (Pubitemid 351265400)
35. Cheuk DK, Wong V 2006 Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet 36:651-659 (Pubitemid 44188080)
36. Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY 2007 A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144B:541-550 (Pubitemid 46983166)
37. Caspi A, Langley K, MilneB, MoffittTE, O'Donovan M, OwenMJ, Polo Tomas M, Poulton R, Rutter M, Taylor A, Williams B, Thapar A 2008 A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 65:203-210 (Pubitemid 351214319)
38. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM 2009 Finding the missing heritability of complex diseases. Nature 461:747-753
39. Neale BM, Medland S, Ripke S, Anney RJ, Asherson P, Buitelaar J, Franke B, Gill M, Kent L, Holmans P, Middleton F, Thapar A, Lesch KP, Faraone SV, Daly M, Nguyen TT, Schafer H, Steinhausen HC, Reif A, Renner TJ, Romanos M, Romanos J, Warnke A, Walitza S, Freitag C, Meyer J, Palmason H, Rothenberger A, Hawi Z, Sergeant J, Roeyers H, Mick E, Biederman J 2010 Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49:906-920
40. Mick E, Todorov A, Smalley S, Hu X, Loo S, Todd RD, Biederman J, Byrne D, Dechairo B, Guiney A, McCracken J, McGough J, Nelson SF, Reiersen AM, Wilens TE, Wozniak J, Neale BM, Faraone SV 2010 Family-based genome-wide associa-tion scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 898-905.e3
41. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, Faraone SV, Nguyen TT, Schafer H, Holmans P, Daly M, Steinhausen HC, Freitag C, Reif A, Renner TJ, Romanos M, Romanos J, Walitza S, Warnke A, Meyer J, Palmason H, Buitelaar J, Vasquez AA, Lambregts-Rommelse N, Gill M, Anney RJ, Langely K, O'Donovan M, Williams N, Owen M, Thapar A, Kent L, Sergeant J, Roeyers H, Mick E, Biederman J, Doyle A, Smalley S, Loo S, Hakonarson H, Elia J, Todorov A, Miranda A, Mulas F, Ebstein RP, Rothenberger A, Banaschewski T, Oades RD, Sonuga-Barke E, McGough J, Nisenbaum L, Middleton F, Hu X, Nelson S 2010 Meta-analysis of genome-wide association studies of attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49:884-897
42. Franke B, Neale BM, Faraone SV 2009 Genome-wide association studies in ADHD. Hum Genet 126:13-50
43. McClellan J, KingMC 2010 Genetic heterogeneity inhuman disease. Cell 141:210-217
44. Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, D'Arcy M, deBerardinis R, Frackelton E, Kim C, Lantieri F, Muganga BM, Wang L, Takeda T, Rappaport EF, Grant SF, Berrettini W, Devoto M, Shaikh TH, Hakonarson H, White PS 2010 Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 15:637-646
45. Sebat J, Levy DL, McCarthy SE 2009 Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 25:528-535
46. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattia-sdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Moller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Muhleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nothen MM, Peltonen L, Collier DA, St Clair D, Stefansson K 2008 Large recurrent microdeletions associated with schizophrenia. Nature 455:232-236
47. Heinzen EL, Radtke RA, Urban TJ, Cavalleri GL, Depondt C, Need AC, Walley NM, Nicoletti P, Ge D, Catarino CB, Duncan JS, Kasperaviciute D, Tate SK, Caboclo LO, Sander JW, Clayton L, Linney KN, Shianna KV, Gumbs CE, Smith J, Cronin KD, Maia JM, Doherty CP, Pandolfo M, Leppert D, Middleton LT, Gibson RA, Johnson MR, Matthews PM, Hosford D, Kalviainen R, Eriksson K, Kantanen AM, Dorn T, Hansen J, Kramer G, Steinhoff BJ, Wieser HG, Zumsteg D, Ortega M, Wood NW, Huxley-Jones J, Mikati M, Gallentine WB, Husain AM, Buckley PG, Stallings RL, Podgoreanu MV, Delanty N, Sisodiya SM, Goldstein DB 2010 Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 86:707-718
48. Coghill D, Banaschewski T 2009 The genetics of attention-deficit/ hyperactivity disorder. Expert Rev Neurother 9:1547-1565
49. Nigg J, Nikolas M, Burt SA 2010 Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psy-chiatry 49:863-873
50. Pennington BF, McGrath LM, Rosenberg J, Barnard H, Smith SD, Willcutt EG, Friend A, Defries JC, Olson RK 2009 Gene X environment interactions in reading disability and attention-deficit/hyperactivity disorder. Dev Psychol 45:77-89
51. Solanto MV 1998 Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127-152 (Pubitemid 28352470)
52. Arnsten AF 2009 The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex. J Pediatr 154:I-S43
53. Purper-Ouakil D, Wohl M, Orejarena S, Cortese S, Boni C, Asch M, Mouren MC, Gorwood P 2008 Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet 147B:1425-1430
54. Nemoda Z, Angyal N, Tarnok Z, Gadoros J, Sasvari-Szekely M 2009 Carboxyles-terase 1 gene polymorphism and methylphenidate response in ADHD. Neuropharmacology 57:731-733
55. Mick E, Neale B, Middleton FA, McGough JJ, Faraone SV 2008 Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B:1412-1418
56. Michelson D, Read HA, Ruff DD, Witcher J, Zhang S, McCracken J 2007 CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 46:242-251 (Pubitemid 46148423)
57. Ramoz N, Boni C, Downing AM, Close SL, Peters SL, Prokop AM, Allen AJ, Hamon M, Purper-Ouakil D, Gorwood P 2009 A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). Neuropsychopharmacology 34:2135-2142
58. Szobot CM, Roman T, Hutz MH, Genro JP, Shih MC, Hoexter MQ, Junior N, Pechansky F, Bressan RA, Rohde LA 2011 Molecular imaging genetics of methyl-phenidate response in ADHD and substance use comorbidity. Synapse 65:154-159
59. Giedd JN, Rapoport JL 2010 Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron 67:728-734
60. Makris N, Biederman J, Monuteaux MC, Seidman LJ 2009 Towards conceptualizing a neural systems-based anatomy of attention-deficit/ hyperactivity disorder. Dev Neurosci 31:36-49
61. Rubia K, Cubillo A, Smith AB, Woolley J, Heyman I, Brammer MJ 2010 Disorder-specific dysfunction in right inferior prefrontal cortex during two inhibition tasks in boys with attention-deficit hyperactivity disorder compared to boys with obsessive-compulsive disorder. Hum Brain Mapp 31:287-299
62. Konrad K, Eickhoff SB 2010 Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp 31:904-916
63. Durston S, Mulder M, Casey BJ, Ziermans T, van Engeland H 2006 Activation in ventral prefrontal cortex is sensitive to genetic vulnerability for attention-deficit hyperactivity disorder. Biol Psychiatry 60:1062-1070 (Pubitemid 44647210)
64. Durston S, Fossella JA, Mulder MJ, Casey BJ, Ziermans TB, Vessaz MN, Van Engeland H 2008 Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. J Am Acad Child Adolesc Psychiatry 47:61-67
65. Sonuga-Barke EJ 2005 Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry 57:1231-1238 (Pubitemid 40798540)
66. Nigg JT, Casey BJ 2005 An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences. Dev Psychopathol 17:785-806
67. Casey BJ, Nigg JT, Durston S 2007 New potential leads in the biology and treatment of attention deficit-hyperactivity disorder. Curr Opin Neurol 20:119-124 (Pubitemid 46411495)
68. Durston S, Fossella JA, Casey BJ, Hulshoff Pol HE, Galvan A, Schnack HG, Steenhuis MP, Minderaa RB, Buitelaar JK, Kahn RS, van Engeland H 2005 Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry 10:678-685 (Pubitemid 40961738)
69. Plomp E, Van Engeland H, Durston S 2009 Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuro-imaging? Neuroscience 164:230-240
70. Arguello PA, Gogos JA 2006 Modeling madness in mice: one piece at a time. Neuron 52:179-196 (Pubitemid 44466363)
71. Sagvolden T 2000 Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31-39 (Pubitemid 30026144)
72. Heyser CJ, Wilson MC, Gold LH 1995 Coloboma hyperactive mutant exhibits delayed neurobehavioral developmental milestones. Brain Res Dev Brain Res 89:264-269
73. Gainetdinov RR, Caron MG 2000 An animal model of attention deficit hyperactivity disorder. Mol Med Today 6:43-44 (Pubitemid 30010236)
74. Besson M, Suarez S, Cormier A, Changeux JP, Granon S 2008 Chronic nicotine exposure has dissociable behavioural effects on control and beta2-/-mice. Behav Genet 38:503-514
75. Moon J, Ota KT, Driscoll LL, Levitsky DA, Strupp BJ 2008 A mouse model of fragile X syndrome exhibits heightened arousal and/or emotion following errors or reversal of contingencies. Dev Psychobiol 50:473-485
76. Sul JH, Kim H, Huh N, Lee D, Jung MW 2010 Distinct roles of rodent orbitofrontal and medial prefrontal cortex in decision making. Neuron 66:449-460
77. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K, Tomonaga S, Watanabe Y, Chung YJ, Banerjee R, Iwamoto K, Kato T, Okazawa M, Yamauchi K, Tanda K, Takao K, Miyakawa T, Bradley A, Takumi T 2009 Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137:1235-1246
78. Kvajo M, McKellar H, Arguello PA, Drew LJ, Moore H, MacDermott AB, Karay-iorgou M, Gogos JA 2008 A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc Natl Acad Sci USA 105:7076-7081 (Pubitemid 351754532)
79. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, St Clair DM, Muir WJ, Blackwood DH, Porteous DJ 2000 Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9:1415-1423 (Pubitemid 30312490)